Home / APLLTD.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does APLLTD.NS make money? Does APLLTD.NS have pricing power? What's the Earnings Whisper? Will APLLTD.NS profit more as the business scales? What is APLLTD.NS's management track record? Is APLLTD.NS's current price justified?

Alembic Pharmaceuticals Limited

₹789.45 -$48.20 (-5.75%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹792.65

Day Range

₹771₹793

Year Range

₹635.8₹998

Market Cap

155.18B

AVG Volume

155.44K

Trailing/Forward PE

22.38/15.69

PEG ratio

2.42

Dividend Yield

1.52%

Next Earnings Date

2026-11-10

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

APLLTD.NS Revenue (INR) by year
Period	Revenue (INR)
2026	73.45B
2025	66.72B
2024	62.29B
2023	56.53B
2022	53.06B
2021	53.93B
2020	46.06B
2019	39.35B
2018	31.3B
2017	31.09B

Net Income (INR) · A

APLLTD.NS Net Income (INR) by year
Period	Net Income (INR)
2026	6.75B
2025	5.83B
2024	6.16B
2023	3.42B
2022	5.21B
2021	11.46B
2020	8.29B
2019	5.84B
2018	4.13B
2017	4.03B

Operating Income (INR) · A

APLLTD.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	14.73B
2025	27.02B
2024	25.09B
2023	19.43B
2022	14.96B
2021	23.32B
2020	19.61B
2019	16.23B
2018	11.66B
2017	100K

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Alembic Pharmaceuticals Limited

Video analysis: APLLTD.NS

News: APLLTD.NS

Similar companies